Literature DB >> 11484892

Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma.

Z W Baloch1, V A LiVolsi.   

Abstract

This paper reviews both clinicopathologic and biological factors in differentiated thyroid carcinoma of follicular and C-cell derivation. The value of specific histological parameters including tumor subtypes, vascular invasion as predictors of prognosis in these tumors is discussed and the pertinent literature reviewed. The utility of ploidy analysis and immunohistochemical assessment of hormonal and tumor markers are described. Current information on biological and molecular markers that may be helpful in predicting behavior is discussed. The commonly used staging systems for thyroid cancer are briefly described.

Entities:  

Mesh:

Year:  2001        PMID: 11484892     DOI: 10.1089/105072501750362709

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  11 in total

1.  Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation.

Authors:  R Parameswaran; J Shulin Hu; N Min En; W B Tan; N K Yuan
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

2.  Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study.

Authors:  Shangtong Lei; Zihai Ding; Junna Ge; Donghui Zhao
Journal:  Oncol Lett       Date:  2015-06-24       Impact factor: 2.967

Review 3.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

4.  All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients.

Authors:  Kristin L Long; Carol Etzel; Thereasa Rich; Samuel Hyde; Nancy D Perrier; Paul H Graham; Jeffrey E Lee; Mimi I Hu; Gilbert J Cote; Robert Gagel; Elizabeth G Grubbs
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

5.  Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.

Authors:  Junyi Wang; Bin Zhang; Wensheng Liu; Yongxia Zhang; Xuebing Di; Yanmei Yang; Dangui Yan
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

Review 6.  [Thyroid tumors].

Authors:  K W Schmid; S-Y Sheu; R Görges; C Ensinger; M Tötsch
Journal:  Pathologe       Date:  2003-09       Impact factor: 1.011

7.  Medullary thyroid carcinoma, follicular variant.

Authors:  Mehtap Cakir; Hasan Altunbas; Mustafa Kemal Balci; Umit Karayalcin; Gulten Karpuzoglu
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 8.  Medical management of metastatic medullary thyroid cancer.

Authors:  Jessica E Maxwell; Scott K Sherman; Thomas M O'Dorisio; James R Howe
Journal:  Cancer       Date:  2014-06-18       Impact factor: 6.860

9.  Sociodemographic Predictors of Survival in Differentiated Thyroid Cancer: Results from the SEER Database.

Authors:  Lily E Johnston; Hop S Tran Cao; David C Chang; Michael Bouvet
Journal:  ISRN Endocrinol       Date:  2012-08-16

Review 10.  The Management of Medullary Thyroid Carcinoma in the Era of Targeted Therapy.

Authors:  Brian Ng-Cheng-Hin; Kate L Newbold
Journal:  Eur Endocrinol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.